|
2024
|
Invention
|
B7-h4 therapeutic binding molecules for the treatment of cancer. The disclosure relates to method... |
|
|
Invention
|
Antibodies to amyloid beta.
Antibody for human amyloid beta. Antibody selectively binds human am... |
|
|
Invention
|
Combination therapy comprising anti-cd22 antibody-drug conjugate and irak1 inhibitor. This disclo... |
|
|
Invention
|
Pyrrolobenzodiazepine-antibody conjugates and uses thereof.
The present disclosure relates to no... |
|
|
Invention
|
Migraine therapy. The disclosure generally provides compositions and methods that are useful in t... |
|
|
Invention
|
Compounds and methods for treating pain.
This disclosure provides compositions and methods for c... |
|
2023
|
Invention
|
Combination therapy for treatment of cancer comprising anti-pd-l1 and anti-cd73 antibodies. The d... |
|
|
Invention
|
Compositions and methods for neoadjuvant treatment in cancer comprising anti-cd39 antibodies. The... |
|
|
Invention
|
Antibody molecule for human gm-csf receptor alpha.
Binding members for alpha chain of receptor f... |
|
|
Invention
|
Anti-b7-h1 antibodies for treating tumors.
Provided herein are methods of treating B7-H1-express... |
|
|
Invention
|
Therapeutic binding molecules.
The present invention relates to binding molecules (e.g. antibodi... |
|
|
Invention
|
Treatment of asthma with an anti-interleukin-33 antibody. The present disclosure relates to metho... |
|
|
Invention
|
Method of selecting patients for treatment with an il-33 axis antagonist. The present disclosure ... |
|
|
Invention
|
Treatment of acute respiratory failure. The present disclosure provides a method of treating or p... |
|
|
Invention
|
Assay for detection of il-33. The present disclosure relates to a method for detecting antigenica... |
|
|
Invention
|
Antibodies to ticagrelor and methods of use.
The disclosure generally provides antibodies and an... |
|
|
Invention
|
Il33 antibodies and methods of using the same.
The present invention provides isolated IL-33 pro... |
|
|
Invention
|
Heterodimeric relaxin fusions and uses thereof. The present invention relates to heterodimeric Re... |
|
|
Invention
|
Pyrrolobenzodiazepines and conjugates thereof. A compound which is either A:
and salts and solv... |
|
|
Invention
|
Composition comprising a pyrrolobenzodiazepine-based antibody drug conjugate. This disclosure rel... |
|
|
Invention
|
Anti-rsv monoclonal antibody formulation.
The present invention provides a formulation comprisin... |
|
|
Invention
|
Rsv-specific antibodies and functional parts thereof. This application provides antibodies and fu... |
|
|
Invention
|
Methods for reducing respiratory infections. The disclosure relates to methods for reducing infec... |
|
|
Invention
|
Combination therapies for treatment of cancer with therapeutic binding molecules.
Provided are m... |
|
|
Invention
|
Combination therapies for treatment of cancer comprising b7-h4 antibody drug conjugate. Provided ... |
|
|
Invention
|
Anti-pad4 autoantibodies as clinical response biomarkers for the treatment of rheumatoid arthriti... |
|
|
Invention
|
Combination therapy with an anti-axl antibody-pbd conjugate and nanocups. This disclosure relates... |
|
|
Invention
|
Anti-par2 antibodies and uses thereof.
The present disclosure provides antibodies and antigen-bi... |
|
|
Invention
|
Glp-1 and glucagon dual agonist peptides with improved biological stability.
GLP-1 and glucagon ... |
|
|
Invention
|
Glp-1 and glucagon dual agonist peptides with improved biological stability. Provided herein are ... |
|
|
Invention
|
Dosage regimen. This disclosure relates to dosage regimens for the treatment of proliferative dis... |
|
|
Invention
|
Antibodies to alpha-synuclein and uses thereof.
The invention provides antibodies that specifica... |
|
2022
|
Invention
|
Treatment using heterodimeric relaxin fusions. The present invention relates to uses of heterodim... |
|
|
Invention
|
Binding molecules specific for cd73 and uses thereof.
The present disclosure provides anti-CD73 ... |
|
|
Invention
|
Anti-il-13ralpha2 conjugates.
This disclosure relates to antibody conjugates comprising antibodi... |
|
|
Invention
|
Anti-psma conjugates.
This disclosure relates to antibody conjugates comprising antibodies that ... |
|
|
Invention
|
Dry powder formulations of thymic stromal lymphopoietin (tslp)-binding antibodies and methods of ... |
|
|
Invention
|
Targeted binding agents against b7-h1.
Human monoclonal antibodies directed against B7-H1 and us... |
|
|
Invention
|
Methods for treating atopic dermatitis and related disorders.
The present invention relates to m... |
|
|
Invention
|
Methods for treating vascular inflammation, atherosclerosis and related disorders.
The present i... |
|
|
Invention
|
An anti-tslp fab with improved stability.
The present disclosure relates to an anti-TSLP Fab wit... |
|
|
Invention
|
Therapeutic binding molecules.
The invention relates to binding molecules, such as antibodies, t... |
|
|
Invention
|
Use of tivozanib and durvalumab for treating hepatocellular carcinoma (hcc). Disclosed herein are... |
|
2021
|
Invention
|
Polypeptides and uses thereof.
Disclosed are polypeptides which are pramlintide analogues and us... |
|
|
Invention
|
Hydrogen peroxide evolved host cell.
A directed evolution method for improving performance of a ... |
|
|
Invention
|
Glycoconjugates.
This disclosure relates to glycoconjugates comprising glycosylated cell-binding... |
|
|
Invention
|
Compounds and methods for treating pain.
The disclosure provides novel methods and dosage regime... |
|
|
Invention
|
A scoring method for an anti-b7h4 antibody-drug conjugate therapy.
The present invention relates... |
|
|
Invention
|
Prevention of axonal damage using antibody binding to amyloid beta 1-42.
The present invention r... |
|
2003
|
P/S
|
Chemicals used in industry, science and photography, as well as in agriculture, horticulture and ... |
